publication of the new recommendations for the injection safe in diabetes

Seville, July 2012.- the WISE consensus Group (Workshop on Injection Safety in Endocrinology) has presented the new recommendations for the safe injection in diabetes. These recommendations are designed to promote the safety of professionals and others with a potential risk of contact with sharps used in the treatment of diabetes.

The recommendations have been developed based on the results of an extensive survey carried out 634 nurses from 13 European countries and Russia for 4 months, and the conclusions of the seminar of the Group of consensus in safe injections in Endocrinology – Injection Safety in Endocrinology (WISE), which took place in October 2011 and gathered 58 experts in the field of security in Diabetes.

A new European directive on the prevention of injury from sharp short instrumental, published in 2010 and that it must be implemented in all countries members as the deadline in may 2013 provides that when there is risk of injury by sharps, users and health professionals should be protected by adequate security measures, including the use of “medical devices with maximum protection security mechanisms”.

Dr. Kenneth Strauss, Global Medical Director, BD, Director of safety in medicine, European Medical Association (EMA), and member of the WISE consensus group, says: activities which face in his day to day health professionals expose them to risk of serious infectionswhich involved more than 30 potentially dangerous pathogens such as HIV and hepatitis viruses, and that they are caused by injuries with contaminated needles and lancets. The European Union produced more than one million of injury by puncture needle each year, but most of these accidents could be avoided with appropriate training, working procedures safer and with the use of devices with security mechanisms ”

the aim of these recommendations is to provide a formal Protocol for the implementation of this Directive in diabetes care. These evidence-based recommendations were prepared and contrasted by a large international group of security experts. The evaluacionn Committee decided to use a scale of criteria depending on the importance of the recommendation score.

The most relevant points were:

– risks to which they are exposed healthcare professionals in diabetes care
-the imminent European legislation
-considerations to take into account on the various devices
-implications of injection techniques
-the creation of a culture of security ” information, awareness-raising and training
-cost-effectiveness of devices
-awareness and responsibility in the Elimination of the cortopunzante material

the present recommendation is based on a review and analysis of recent studies and publications in the field of security in injections into diabetes.

The 2012, may 10 was celebrated in Seville a day where gathered professionals from the world of diabetes at the national level and in which presented the new recommendations WISE ” in Spain. Among key Spain practitioners who attended the day are responsible for prevention of occupational hazards, nursing supervisors, coordinators, directors of nursing, and educating nurses in diabetes. The main topics covered in the seminar were: increasing awareness of health professionals about the new European directive for the prevention of injury from sharps and its legal implications, the presentation of the new WISE recommendations for safe injection in diabetes ”, developed to help healthcare organizations comply with the directive, and share information and experience on safe injections of insulin.

The new WISE recommendations for safe injection in diabetes are available at: http://www.sciencedirect.com/science/article/pii/S1262363612709758.